INTENSITY THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
INTENSITY THERAPEUTICS, INC. (INTS) reported Adjustments to Additional Paid in Capital, Warrant Issued of $159.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-03-13
- INTENSITY THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-12-31 was -$262.00.
- INTENSITY THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-09-30 was $0.00.
- INTENSITY THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $262.00.
- INTENSITY THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-03-31 was $159.00K.
- INTENSITY THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $159.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$262.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$262.00 derived: sum of 2 quarters · filed 2025-03-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-13 | $159.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $262.00 derived: sum of 2 quarters · filed 2023-11-13 | $159.26K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $262.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $159.26K 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $159.00K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |